ONWARD Medical: steady execution in Q3 2024
This morning, ONWARD shared a Q3 business update highlighting major YTD achievements across clinical development, IP and corporate actions. While the update contained no surprises, we appreciate the highly productive quarter, during which the company steadily delivered on all three fronts aligned w
Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.